Title: Understanding physiologic changes in ataxia
1Understanding physiologic changes in ataxia
2Cells of the cerebellum
3Physiologic features of cerebellar neurons
- Pacemaker neurons Purkinje and DCN neurons
- Neurotransmitter systems GABA projection neurons
(Purkinje neurons) - Glutamatergic projection neurons (DCN neurons)
- Interneurons GABA Golgi, Basket, Stellate,
Lugaro. Glutamate UBN
4Cerebellar circuitry
- Cerebellar Input
- Climbing fibers Inferior olive
- Mossy fibers All other input
- Cerebellar output
- DCN projections
- Vestibulocerebellum- direct projections from PC
to vestibular nuclei
5How does the cerebellum work?
6Why bother understanding Physiologic changes in
Ataxia?
- Mutations in ion channels. Neuronal dysfunction
from perturbed channel activity - Perturbations in ion channel physiology in the
absence of a primary channel defect - Novel therapeutic targets for symptomatic
treatment of ataxia.
7(No Transcript)
8Why study cerebellar physiology?
Ataxic channelopathies Ataxic channelopathies
Disorder SCA6 SCA13 SCA15 Episodic ataxia 1 Episodic ataxia 2 Episodic ataxia 5 SMEI Ion channel mutation (gene/protein) CACNA1A/Cav2.1 KCNC3/Kv3.3 ITPR1/IP3 receptor KCNA1/Kv1.1 CACNA1A/Cav2.1 CACNB4/Cav2.1 auxiliary subunit SCN1A/Nav1.1
Ataxias associated with channel dysfunction without channel mutations Ataxias associated with channel dysfunction without channel mutations
Disorder SCA27 SCA5 DRPLA Episodic ataxia 6 Paraneoplastic cerebellar ataxia Ion channel involved Nav1.6 Ionotropic glutamate receptors Ionotropic glutamate receptors, GABAA receptors Ionotropic glutamate receptors Cav2.1
9Ataxia from ion-channel mutations
Ataxic channelopathies Ataxic channelopathies Ataxic channelopathies
Disorder Ion channel mutation (gene/protein) Type of mutation
SCA6 CACNA1A/Cav2.1 ?Haploinsufficiency/ ?Gain of function
SCA13 KCNC3/Kv3.3 Dominant-negative
SCA15 ITPR1/IP3 receptor Dominant negative
Episodic ataxia 1 KCNA1/Kv1.1 Dominant-negative
Episodic ataxia 2 CACNA1A/Cav2.1 Haploinsuffiency
Episodic ataxia 5 CACNB4/Cav2.1 Auxiliary subunit ?Haploinsufficiency/ ?Dominant negative
SMEI SCN1A/Nav1.1 Haploinsufficiency
10No channel mutation but channels involved
Ataxias associated with channel dysfunction without channel mutations Ataxias associated with channel dysfunction without channel mutations
Disorder Ion channel involved
SCA27 Nav1.6
SCA5 Ionotropic glutamate receptors
DRPLA Ionotropic glutamate receptors, GABAA receptors
Episodic ataxia 6 Ionotropic glutamate receptors
Paraneoplastic Cerebellar ataxia Cav2.1
11(No Transcript)
12SCA6
- CAG repeat/polyglutamine disorder
- Expansion of a polyglutamine tract in the
carboxyl terminus (C-terminus) of the P/Q type
voltage-gated calcium channel alpha subunit,
Cav2.1 - A relatively pure cerebellar syndrome, SCA6 is
notable for selective degeneration of cerebellar
Purkinje neurons
13SCA6
- Precise mechanism by which the altered Cav2.1
protein causes ataxia remains uncertain - Altered channel function (haploinsufficiency)?
- Production of an aberrant C-terminal fragment
(gain of function)?
14SCA13
- Mutations in the KCNC3 gene encoding the
voltage-gated potassium channel protein, Kv3.3 - Purkinje neurons in null mice display broader
action potentials, fail to sustain high frequency
firing in response to injected current, and have
reduced burst frequency in response to climbing
fiber stimulation - The cerebellar atrophy seen in patients with
SCA13 has been hypothesized to be due to
increased calcium entry into Purkinje neurons
secondary to the spike broadening seen in the
null mice
15Episodic ataxia 1 (EA1)
- Mutations in the voltage-gated potassium
channel, KCNA1 (Kv1.1) - Purkinje neurons show increased GABAergic
inhibitory postsynaptic currents (IPSCs) - Kv1.1 normally hyperpolarizes axon branch points
of Basket neurons, preventing some action
potentials from reaching the presynaptic terminal - More action potentials to invade presynaptic
terminal?
16EA1
wikipedia
Basket cell showing axon branch points
How does acetazolamide work?
17EA2 and EA5
- Mutations in CACNA1A
- EA2 is allelic with SCA6 and familial hemiplegic
migraine - More than 20 CACNA1A mutations have been
identified which result in a truncated,
nonfunctional protein - Attacks of ataxia and migraine-like symptoms that
may be precipitated by physical and emotional
stress, coffee or alcohol - Signs of cerebellar dysfunction can be present
between the paroxysmal episodes - Another form of episodic ataxia, EA5, is caused
by mutations in CACNB4 which encodes an auxiliary
beta subunit of Cav2.1
18EA2
- Mutations in the P/Q-type voltage-gated calcium
channel, Cav2.1, leads to reduced calcium current
density - Impaired synaptic transmission at the parallel
fiber-Purkinje neuron synapse - Reduced precision of intrinsic pacemaker firing
by Purkinje neurons
19EA2
- A calcium-activated potassium channel opener
improves motor behavior in mice - Acetazolamide prevents or attenuates attacks in
50 to 75 of patients. - Acetazolamide-induced changes in intracellular pH
and the resulting change in potassium channel
conductance may explain the therapeutic effect of
the drug
20SCA27
- SCA27 was first described in a Dutch pedigree
manifesting childhood-onset postural tremor and
slowly progressive ataxia beginning in young
adulthood - Orofacial dyskinesias, postural limb tremor,
disorders of executive function and non-verbal
memory often occur - Mutations in the fibroblast growth factor 14
(FGF14) gene cause SCA27
21SCA27
- Although SCA27 is not caused by an ion channel
mutation, the ataxic phenotype in this disorder
results from perturbed expression of
voltage-gated sodium channels in cerebellar
neurons - Most Purkinje neurons in a mouse model of SCA27
do not fire spontaneously - There is reduced expression of Nav1.6 in Purkinje
neurons - Mutant FGF14 protein fails to interact with
sodium channel subunits, and interferes with the
interaction between wild-type FGF14 and
voltage-gated sodium channel subunits in a
dominant manner
22Paraneoplastic cerebellar ataxia
- Cerebellar ataxia sometimes occurs in association
with LambertEaton myasthenic syndrome (LEMS) - LEMS immune-mediated disorder of the
neuromuscular junction associated with antibodies
directed against the voltage gated P/Q type
calcium channel, Cav2.1 - Cerebellar symptoms were in a recent study
present in 9 of 97 patients with LEMS, in nearly
all cases associated with small cell lung cancer
23Paraneoplastic cerebellar ataxia
- When applied to cerebellar slices, an antibody
directed againt Cav2.1 reduced synaptic
transmission at the parallel fiberPurkinje cell
synapse - An anti-Cav2.1 antibody conferred an ataxic
phenotype by passive transfer in mice
24How about the degenerative ataxias?
- Neuronal loss does not explain all the phenotypic
changes in the degenerative ataxias - For example mouse models of SCA1 show a
neurological phenotype prior to significant
neuronal cell loss - Expression of expanded (pathogenic) ataxin-3 in
differentiated neural cells caused
electrophysiologic dysfunction preceding the
onset of nuclear inclusions and ultrastructural
morphological changes
25Postulated mechanism for altered physiology and
ataxia